CD8A and melanoma: CD8+ T-cell clones with higher avidity for NY-ESO-160–72-HLA-B*07:02 tetramer (Supplementary Fig. 1) correlated well with their activation by lower peptide concentration (Fig. 1f) and by melanoma cells (Fig. 1e).